Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-011017
Filing Date
2015-07-08
Accepted
2015-07-08 16:50:35
Documents
2
Period of Report
2015-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2846
2 POWER-OF-ATTORNEY poamarino.txt EX-24 3731
  Complete submission text file 0001179110-15-011017.txt   8105
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCONOVA THERAPEUTICS 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
MARINO JAMES J (Reporting) CIK: 0001198578 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 15979653